| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a68f9e0a60539e5ba3fae013aabf31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6a080bddc9c50297b1ce37c31f46d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_200dc3f1a4b6e98034294a37e7938b14 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82f6f8f2b47f1d54c1e87c8a873ac8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9181ce529f1ab99529d2205c5370bef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b80824ace1ad7928c4a396b00e3cef9 |
| publicationDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013064806-A1 |
| titleOfInvention |
Novel pharmaceutical salts and polymorphs of a factor xa inhibitor |
| abstract |
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9061019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644195-B2 |
| priorityDate |
2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |